Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000252589 | SCV000311947 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000391294 | SCV000471979 | uncertain significance | Primary ciliary dyskinesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000551113 | SCV000652496 | benign | Primary ciliary dyskinesia 19 | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002285295 | SCV002575136 | likely benign | not provided | 2021-01-18 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Ambry Genetics | RCV000391294 | SCV002755802 | benign | Primary ciliary dyskinesia | 2017-04-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV002285295 | SCV004563236 | benign | not provided | 2023-08-21 | criteria provided, single submitter | clinical testing |